KREBSBIO2023-10-012023-12-31 KREBSBIO2023-10-012023-12-31 KREBSBIO2023-10-012023-12-31in-bse-fin:OneOperatingExpenses01Member KREBSBIO2023-10-012023-12-31in-bse-fin:FourOperatingExpenses01Member KREBSBIO2023-12-31 iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 524518 KREBSBIO NA Krebs Biochemicals and Industries Limited Equity 2023-04-01 2024-03-31 2024-02-12 2024-01-19 INR Lakhs Third quarter 12:00:00 13:20:00 2024-02-12 2024-02-12 Not applicable Single segment Manufacturing of Drugs 2023-10-01 2023-12-31 Unaudited Standalone 129772000.00 294000.00 130066000.00 10309000.00 0.00 2465000.00 44447000.00 11862000.00 17305000.00 93452000.00 179840000.00 -49774000.00 0.00 -49774000.00 0.00 0.00 0.00 0.00 -49774000.00 0.00 0.00 0.00 0.00 -49774000.00 0.00 -49774000.00 0.00 0.00 215606000.00 10 -2.31 -2.31 0.00 0.00 -2.31 -2.31 0.00 0.00 0.00 1. The above results have been reviewed by the Audit Committee at its meeting held on 12th February, 2024 and approved by the Board of Directors of the Company at its meeting held on 12th February, 2024. The results are subjected to limited review by statutory auditors. 2. The Company is operating in one segment only hence no segment results have been disclosed. 3. The above financial results are prepared in accordance with IND AS notified under the Company (Indian Accounting Standards) Rules, 2015. Single segment 2023-04-01 2023-12-31 Unaudited Standalone 384486000.00 2411000.00 386897000.00 36251000.00 0.00 714000.00 125974000.00 34176000.00 50945000.00 277652000.00 525712000.00 -138815000.00 0.00 -138815000.00 0.00 0.00 0.00 0.00 -138815000.00 0.00 0.00 0.00 0.00 -138815000.00 0.00 -138815000.00 0.00 0.00 215606000.00 10 -6.44 -6.44 0.00 0.00 -6.44 -6.44 0.00 0.00 0.00 Other Expenses 93452000.00 Other Expenses 277652000.00